Gene · 2913
Papers2,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 2,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants. | Pharmaceuticals (Basel) | 2015 | 26393618 | PubTator, text mining | PubMed |
| Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia. | Mol Neuropsychiatry | 2015 | 26380821 | PubTator, text mining | PubMed |
| Metabotropic Glutamate Receptor 2 Positive Allosteric Modulators: Closing the Gate on Drug Abuse? | Biol Psychiatry | 2015 | 26360546 | PubTator, text mining | PubMed |
| Selective Negative Allosteric Modulation Of Metabotropic Glutamate Receptors – A Structural Perspective of Ligands and Mutants. | Sci Rep | 2015 | 26359761 | PubTator, text mining | PubMed |
| Dependence of Human Colorectal Cells Lacking the FBW7 Tumor Suppressor on the Spindle Assembly Checkpoint. | Genetics | 2015 | 26354767 | PubTator, text mining | PubMed |
| Glutamatergic Transmission: A Matter of Three. | Neural Plast | 2015 | 26345375 | PubTator, text mining | PubMed |
LY395756, an mGluR2 agonist and mGluR3 antagonist, enhances NMDA receptor expression and function in the normal adult rat prefrontal cortex, but fails to improve working memory and reverse MK801-induced working memory impairment. | Exp Neurol | 2015 | 26341392 | PubTator, text mining | PubMed |
| Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents. | J Med Chem | 2015 | 26335039 | PubTator, text mining | PubMed |
Synthesis and Pharmacological Characterization of C4-(Thiotriazolyl)-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1R,2S,4R,5R,6R)-2-Amino-4-(1H-1,2,4-triazol-3-ylsulfanyl)bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2812223), a Highly Potent, Functionally Selective mGlu2 Receptor Agonist. | J Med Chem | 2015 | 26313429 | PubTator, text mining | PubMed |
| Autoregulatory loop between TGF-β1/miR-411-5p/SPRY4 and MAPK pathway in rhabdomyosarcoma modulates proliferation and differentiation. | Cell Death Dis | 2015 | 26291313 | PubTator, text mining | PubMed |
| Conformational dynamics of a class C G-protein-coupled receptor. | Nature | 2015 | 26258295 | PubTator, text mining | PubMed |
| Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas. | Nat Genet | 2015 | 26214590 | PubTator, text mining | PubMed |
| Evaluation of relationship between GRM3 polymorphisms and cognitive function in schizophrenia of Han Chinese. | Psychiatry Res | 2015 | 26187343 | PubTator, text mining | PubMed |
| Further optimization of the mGlu5 PAM clinical candidate VU0409551/JNJ-46778212: Progress and challenges towards a back-up compound. | Bioorg Med Chem Lett | 2015 | 26183084 | PubTator, text mining | PubMed |
| MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del. | PLoS One | 2015 | 26173148 | PubTator, text mining | PubMed |
| Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration. | PLoS One | 2015 | 26151906 | PubTator, text mining | PubMed |
| Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment. | Trends Neurosci | 2015 | 26148747 | PubTator, text mining | PubMed |
| Re-visiting the nature and relationships between neurological signs and neurocognitive functions in first-episode schizophrenia: An invariance model across time. | Sci Rep | 2015 | 26136150 | PubTator, text mining | PubMed |
| Tumor-suppressor Genes, Cell Cycle Regulatory Checkpoints, and the Skin. | N Am J Med Sci | 2015 | 26110128 | PubTator, text mining | PubMed |
| Dietary Intake of Sulforaphane-Rich Broccoli Sprout Extracts during Juvenile and Adolescence Can Prevent Phencyclidine-Induced Cognitive Deficits at Adulthood. | PLoS One | 2015 | 26107664 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2913/papers?page=55